ChrystalULouisMD
Pediatric Hematology & Oncology • Houston, TXAssistant Professor, Pediatric Hematology & Oncology, Baylor College of Medicine
Are you Dr. Louis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4890Fax+1 713-798-1144- Is this information wrong?
Summary
- Dr. Chrystal Louis, MD is a pediatric hematologist/oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas and California. She is an Assistant Professor at Baylor College of Medicine.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
University of California Davis HealthResidency, Pediatrics, 2001 - 2004
Tulane University School of MedicineClass of 2001
Certifications & Licensure
TX State Medical License 2007 - 2024
CA State Medical License 2002 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients Start of enrollment: 2003 Apr 01
- A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells Start of enrollment: 2008 Jun 01
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes Start of enrollment: 2009 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 64 citationsOpen-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerZev A. Wainberg, Howard S. Hochster, Edward J. Kim, Ben George, Aparna Kaylan, E. Gabriela Chiorean, David M. Waterhouse, Martin Guiterrez, Aparna Raj Parikh, Rishi Ja...> ;Clinical Cancer Research. 2020 Sep 15
- 9 citationsNomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer.David Goldstein, Daniel D. Von Hoff, E. Gabriela Chiorean, Michele Reni, Josep Tabernero, Ramesh K. Ramanathan, Marc F. Botteman, Abdalla Aly, Sandra Margunato-Debay, ...> ;Pancreas. 2020 Jul 1
- 11 citationsSafety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small...Jonathan W. Goldman, David M. Waterhouse, Ben George, Peter J. O'Dwyer, Rafia Bhore, Sibabrata Banerjee, Larry Lyons, Chrystal U. Louis, Teng Jin Ong, Karen Kelly> ;Frontiers in Oncology. 2019 Nov 26
- Join now to see all
Professional Memberships
- Member
